Question 1

Who are the top researchers at Nuvisan (Germany)?

Accepted Answer

Ranked on the quality score, Robert J. Nelson and Christian Reh lead among researchers whose main affiliation is Nuvisan (Germany).

Question 2

What are the most cited papers from Nuvisan (Germany)?

Accepted Answer

The most cited paper from Nuvisan (Germany) is "Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer" (Ezra E.W. Cohen et al., 2014), with 579 citations. Next come "Solution Conformations Shed Light on PROTAC Cell Permeability" (201) and "The Effect of Hematocrit on Bioanalysis of DBS: Results from The EBF DBS-Microsampling Consortium" (134).

Question 3

Which research topics does Nuvisan (Germany) publish most on?

Accepted Answer

By volume in 2022-now: Cancer Research and Treatments, Biosimilars and Bioanalytical Methods, Computational Drug Discovery Methods and Cancer, Lipids, and Metabolism.

Question 4

Which keywords describe research at Nuvisan (Germany)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer, Cancer Therapy, Inflammation, Immunotherapy, Monoclonal Antibodies, Tumor Microenvironment, Tumor Regression and Transcriptional Regulation.

Question 5

Which fields of science does Nuvisan (Germany) work in?

Accepted Answer

In 2022-now, 58% of research at Nuvisan (Germany) is in Life Sciences, 28% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (42%), Medicine (27%), Immunology and Microbiology (9%). It does 3.1× the world's share of Life Sciences.

Question 6

Is Nuvisan (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 94% higher than in 2018-2021.